Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia

G Rajagopal, J. G. Graham, F. F. A. Haut

    Research output: Contribution to journalArticlepeer-review

    12 Citations (Scopus)

    Abstract

    While clozapine is an effective treatment for refractory schizophrenia, its use is limited by haematological side effects. Treatment options that allow continued prescription of clozapine by tackling these side effects will greatly aid patients for whom this medication is all too often their only hope of recovery.
    Original languageEnglish
    Pages (from-to)82-85
    Number of pages4
    JournalJournal of Intellectual Disability Research
    Volume51
    Issue number1
    DOIs
    Publication statusPublished - 2007

    Keywords

    • Adult
    • Agranulocytosis
    • Clozapine
    • Comorbidity
    • Drug Therapy, Combination
    • Granulocyte Colony-Stimulating Factor
    • Humans
    • Injections, Subcutaneous
    • Intellectual Disability
    • Leukocyte Count
    • Leukopoiesis
    • Lithium Carbonate
    • Male
    • Schizophrenia, Paranoid

    Fingerprint

    Dive into the research topics of 'Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia'. Together they form a unique fingerprint.

    Cite this